accountNEW YORK, December 16 (newratings.com) - Analysts at UBS initiate coverage of Eli Lilly (ticker: LLY) with a "neutral" rating. [more]...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Eli Lilly initiated with "neutral"
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account